| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |